Research

Biorasi

A Randomized, Multicenter, Investigator-Masked, Parallel Group, Equivalence Study of Once Daily Brimonidine Tartrate Ophthalmic Suspension Compared with Three Times Daily Alphagan P in Subjects with Open Angle Glaucoma or Ocular Hypertension

CVisc50

A Study to Document the Safety and Effectiveness of a New Ophthalmic Viscosurgical Device(OVD) when Compared to a Control OVD.

BL945

A Prospective, Multicenter, Randomized, Active-Controlled Clinical Study to Evaluate the Safety and Effectiveness of the enVista One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens in Subjects Undergoing Cataract Extraction.

Alcon ILR431b-P001

Post Approval Study of the AcrySof IQ ReSTOR Toric IOLs.

NCX-470-02

A Phase 3, Randomized, Adaptive Dose-Selection, Multi-Regional, Double-Masked, Parallel-Group, 3-Month Trial Evaluating the Safety and Efficacy of NCX 470 vs. Latanoprost in Subjects with Open-Angle Glaucoma or Ocular Hypertension.

CLOSE-1 Study

A Phase 3, multicenter, randomized, double-masked clinical trial to assess the efficacy and safety of clobetasol 0.05% ophthalmic nanoemulsion compared to placebo in the treatment of inflammation and pain associated with cataract surgery.